Jozien Helleman

Jozien Helleman

UNVERIFIED PROFILE

Are you Jozien Helleman?   Register this Author

Register author
Jozien Helleman

Jozien Helleman

Publications by authors named "Jozien Helleman"

Are you Jozien Helleman?   Register this Author

20Publications

289Reads

42Profile Views

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens.

Histopathology 2019 Sep 2;75(3):338-345. Epub 2019 Aug 2.

Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851781PMC
September 2019

Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative.

Eur Urol Oncol 2019 Sep 26. Epub 2019 Sep 26.

Department of Surgery, Faculty of Medicine, Monash University, Melbourne, Victoria, Australia; Department of Urology, Monash Health, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.08.014DOI Listing
September 2019

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.

Eur Urol Oncol 2019 May 13;2(3):333-336. Epub 2018 Sep 13.

Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S25889311183013
Publisher Site
http://dx.doi.org/10.1016/j.euo.2018.08.017DOI Listing
May 2019

Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices.

Transl Androl Urol 2018 Feb;7(1):83-97

Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2017.12.24DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861285PMC
February 2018

APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma.

Clin Cancer Res 2016 Sep 25;22(18):4746-55. Epub 2016 Mar 25.

Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota. Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Howard Hughes Medical Institute, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/03/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-2910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026552PMC
September 2016

miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.

Mol Cancer 2015 Nov 17;14:196. Epub 2015 Nov 17.

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-015-0464-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650519PMC
November 2015

MicroRNAs in ovarian cancer biology and therapy resistance.

Int J Biochem Cell Biol 2010 Aug 18;42(8):1282-90. Epub 2010 Jan 18.

Dept. of Medical Oncology, Josephine Nefkens Institute, Erasmus MC, 3015 GE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2010.01.014DOI Listing
August 2010

Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture.

Gynecol Oncol 2010 May 4;117(2):170-6. Epub 2010 Feb 4.

Department of Medical Oncology, Erasmus MC-JNI-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.01.010DOI Listing
May 2010

Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGFbeta and regulating microRNAs.

Int J Biochem Cell Biol 2010 Jan 23;42(1):25-30. Epub 2009 Oct 23.

Department of Medical Oncology, Erasmus MC/JNI, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2009.10.016DOI Listing
January 2010

Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter.

Cancer Biol Ther 2006 Aug 2;5(8):943-9. Epub 2006 Aug 2.

Department of Medical Oncology, Erasmus MC/Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.5.8.2876DOI Listing
August 2006

Mismatch repair and treatment resistance in ovarian cancer.

BMC Cancer 2006 Jul 31;6:201. Epub 2006 Jul 31.

Department of Medical Oncology, Erasmus MC/Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-6-201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557864PMC
July 2006

Molecular profiling of platinum resistant ovarian cancer.

Int J Cancer 2006 Apr;118(8):1963-71

Department of Medical Oncology, Erasmus MC/Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21599DOI Listing
April 2006

Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.

Int J Cancer 2003 Jan;103(3):387-92

Department of Clinical Chemistry, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.10858DOI Listing
January 2003